An international research team has developed an intelligent device capable of monitoring the skin continuously and accurately detect temperature variations associated with inflammation and infection.
Researchers have succeeded in producing sensors from single-wall carbon nanotubes that are suitable for detecting even minute changes in specific substances in the body, such as female hormones.
A sensor, similar to glucose monitoring devices, detects lung cancer biomarkers from a blood sample in just 40 minutes. The technology has potential to identify at-risk patients and tailor treatments.
A new way to inhibit the proliferation of Sars-CoV-2 opens up new perspectives in the fight against this coronavirus and other viral diseases that still have no medical treatment.
Highlights: Fingerstick capillary testing for Lac, Hb, and HctThe StatStrip LAC/Hb /Hct is a handheld, easy-to-use meter that measures lactate, haemoglobin and haematocrit at the point-of-care using two disposable biosensors and tiny capillary blood samples for all tests. Available as a fully connected, wi-fi meter, or a smaller Xpress style meter.Capillary samplingMeasured Hb and measured Hct in…
Highlights: Lactate, haemoglobin, haematocrit, glucose, and ketone for early patient assessment and treatmentFingerstick capillary sampleResults as fast as 6 secondsLaboratory-quality accuracyDurable carrying case holds meters, single-use biosensors, controls, and lancetsEMS Stat* offers simple, fast, and accurate testing in the field. Two meter systems are available. One provides patient data…
Highlights: Fingerstick capillary testing for creatinineThe StatSensor Creatinine is a handheld analyser and miniaturized, single-use biosensor for whole blood creatinine testing. StatSensor Creatinine’s advanced technology enables simple, rapid, and accurate assessment of renal function by fingerstick capillary blood sampling at the point of care. Available as a fully connected meter,…
Taipei City is set to make a splash at the Medica 2024 trade fair. The city's Department of Economic Development has curated an exhibition area, featuring six innovative biotech companies.
Early detection and management of asthma and COPD is critical. US researchers have developed a deep learning model paired with a wearable sensor patch to automatically detect wheezing sounds.
Diagnosis and monitoring medical conditions, including cancer, diabetes, heart disease, and infections: In this opinion article, Alix Joseph (Linxens) explores the potential of sweat analysis.
Artificial cells to combat cancer: Research groups are working to create synthetic micro-organisms capable of detecting the presence of the disease and delivering anti-cancer therapies.
A newly-developed biosensor could be an alterative to MRI and mammography for breast cancer screening. The handheld device uses saliva on test strips to determine whether cancer is present.
Smart catheters, smart diapers or wound dressings: a new approach to wireless biosensors from Malmö University opens up options for more patient-controlled ways of infection detection.
A team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer’s and Parkinson’s Diseases. The biosensor can also transmit the results wirelessly.
Over the last 20 years, the development of lab-on-a-chip (LoC) devices for performing real-time PCR (LoC-PCR) has been an active research field. Now, Italian researchers present their design for a new lab-on-a-chip-PCR device.
Faster, more accurate and cost-effective testing: Experts outline the beginnings and evolution of “lab-on-a-chip” technology, and its benefits for advanced and next-gen operational platforms.
Researchers in Spain have developed a system using patient cells which represents the first 3D muscle model capable of replicating the damage caused by Duchenne muscular dystrophy (DMD).
Basque researchers propose a bioelectronic device consisting of gold electrodes coated with a smart polymer capable of capturing and releasing cells in a non-invasive, controllable way.
Scientists from the University of California San Diego and their colleagues in Australia have engineered bacteria that can detect the presence of tumor DNA in a live organism.
Combining aerosol sampling and ultrasensitive biosensing, researchers have created a real-time monitor that can detect any of the Sars-CoV-2 virus variants in a room in about 5 minutes.
Post-pandemic problems, ageing societies, the impact of climate change on human health: To find solutions for new and ongoing healthcare challenges, thinking outside the box is crucial. This year’s Medical Taiwan Health & Care Expo took this approach to heart: True to its motto “beyond healthcare”, the event showcased a wide range of innovative products, promising start-up presentations…
A research team from DGIST develops an electronic medicine technology that restores abnormal protein behavior, the cause of Charcot-Marie-Tooth Disease (CMT).
Canadian researchers are developing a new, ultra-sensitive biosensor to screen for Alzheimer’s disease and other diseases. The device has successfully completed the proof-of-concept stage.
Speed or accuracy? As far as Covid-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.
With the rise of syndrome-style infections, co-infections and the current antimicrobial resistance challenges, the need for multiplexed diagnostics is now more important than ever.
Researchers at Nottingham Trent University and Nottingham University Hospitals NHS Trust have developed a new biosensor capable of accurately monitoring the condition of a chronic wound.
Avian flu, MERS, Covid-19, monkeypox: outbreaks of infectious diseases are getting more common in Europe. As a result, the EU must adapt its surveillance strategies and introduce more data-driven, interdisciplinary countermeasues.
Researchers created a special ultrathin sensor, spun from gold, that can be attached directly to the skin without irritation or discomfort. The sensor can measure different biomarkers or substances to perform on-body chemical analysis.
This overview introduces connected and continuous glucose sensing technologies, smart insulin delivery systems and more innovations that help patients and doctors monitor and manage glucose levels and guide decision-making in diabetes care.
A wireless, bioelectronic pacifier could eliminate the need for invasive, twice-daily blood draws to monitor babies’ electrolytes in Newborn Intensive Care Units or NICUs.
Point-of-care testing (POCT) is a “win-win” scenario for patients and healthcare professionals in delivering care when and where it is needed, according to pathologist Adil Khan, MSc, PhD.
The AI-Guided Ultrasound Intervention Device is a lifesaving technology that helps a range of users deliver complex medical interventions at the point of injury.
More than 15 billion batteries are sent to landfill sites every year – technology that converts glucose and oxygen into electricity has the potential to reduce this waste and serve as a sustainable alternative power source for medical devices.
Scientists have developed a prototype sensor that could help rapidly measure adenosine triphosphate and lactate levels in blood samples, aiding in the rapid assessment of disease severity.
Researchers in Zurich have developed a fluorescent orexin biosensor to observe on of the brain's signaling molecules "live" to gain insights into constant daytime sleepiness (narcolepsy).
Researchers have developed a smartwatch that assesses cortisol levels found in sweat. The device opens new possibilities for personal health monitoring.
Considerable advances in point-of-care testing (POCT) devices are emerging from lab-on-a-chip platforms, innovations in smartphone-based technology and wearable technology. Cloud-based deep learning systems herald a future revolution.
An international research team from Saudi Arabia, Germany, and Jordan has developed a novel pathogen aptasensor swab designed to qualitatively detect, within five minutes, any methicillin-resistant Staphylococcus aureus (MRSA) contamination that remains in a hospital isolation room or other surface following standard decontamination and cleaning.
The Covid-19 pandemic made it clear technological innovations were urgently needed to detect, treat, and prevent the SARS-CoV-2 virus. A year and a half into this epidemic, waves of successive outbreaks and the dire need for new medical solutions — especially testing — continue to exist. In the Journal of Vacuum Science & Technology B, researchers from the University of Florida and…
Researchers at the University of Arizona are developing a Covid-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes. The research team, led by biomedical engineering professor Jeong-Yeol Yoon, aims to combine the speed of existing nasal swab antigen tests with the high accuracy of nasal swab PCR, or polymerase chain reaction,…
Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer primarily based on PSA, a cancer factor in blood. However, as diagnostic accuracy is as low as 30%, a considerable number of patients undergo additional invasive biopsy and thus suffer from resultant side effects, such as bleeding and pain.
A new type of ultra-efficient, nano-thin material could advance self-powered electronics, wearable technologies and even deliver pacemakers powered by heart beats.
Bacterial infections have become one of the biggest health problems worldwide, and a recent study shows that COVID-19 patients have a much greater chance of acquiring secondary bacterial infections, which significantly increases the mortality rate.
Chronic illnesses can have a dramatic impact on a patient's later life. An early diagnosis of such diseases opens up the possibility of taking medical action in good time.
Researchers at the U.S. National Institute of Standards and Technology (NIST) have developed a new method of 3D-printing gels and other soft materials. Published in a new paper, it has the potential to create complex structures with nanometer-scale precision. Because many gels are compatible with living cells, the new method could jump-start the production of soft tiny medical devices such as…
Roswell Biotechnologies, Inc., a manufacturer of molecular electronics sensor chips, and imec, a research and innovation hub in nanoelectronics and digital technologies, announced a partnership to develop the first commercially available molecular electronics biosensor chips. These chips are the brains behind Roswell Technologies' new platform for DNA sequencing, to support precision medicine,…
Diabetes is called an incurable disease because once it develops, it does not disappear regardless of treatment in modern medicine. Having diabetes means a life-long obligation of insulin shots and monitoring of blood glucose levels. Recently, a research team at Pohang University of Science and Technology developed a wirelessly driven ‘smart contact lens’ technology that can detect diabetes…
A team of researchers from Empa, ETH Zurich and Zurich University Hospital has succeeded in developing a novel sensor for detecting the new coronavirus. In future it could be used to measure the concentration of the virus in the environment - for example in places where there are many people or in hospital ventilation systems. Jing Wang and his team at Empa and ETH Zurich usually work on…
European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes.
The EU four-year project ELSAH, which began at the dawn of 2019, aims to design a wearable to enable continuous determination of biomarker concentrations. Project coordinator Dr Joerg Schotter, Molecular Diagnostics, Centre for Health & Bioresources, AIT Austrian Institute of Technology GmbH, explains the project’s objectives and potential applications for the planned wearable.
Researchers have created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders.
Scientists from Scotland are developing a low cost, rapid diagnostic sensor test which aims to show the susceptibility of bacteria to antibiotics within 45 minutes. Laboratory testing of samples can take up to two days and the new test aims to allow doctors to be able to prescribe the correct antibiotic to a patient for an infection more quickly. In a research paper published in the journal…
A little bit of norovirus – the highly infectious microbe that causes about 20 million cases of food poisoning in the United States each year – goes a long way. Just 10 particles of the virus can cause illness in humans. A team of University of Arizona researchers has created a simple, portable and inexpensive method for detecting extremely low levels of norovirus. Jeong-Yeol Yoon, a…
Point-of-care testing (POCT) is complex and its development continues due to digitisation in healthcare and increasing international partnerships among the healthcare actors. In a hospital, a number of factors need consideration to fully exploit the potential of bedside testing. POCT instruments and analysis methods must be thoroughly validated and quality assurance processes be in place.…
Researchers at the University of Strathclyde have developed an innovative, low cost test for earlier diagnosis of sepsis which could save thousands of lives. The simple system for sensitive real-time measurement of the life threatening condition is much quicker than existing hospital tests, which can take up to 72 hours to process. Using a microelectrode, a biosensor device is used to detect if…
Researchers at McMaster University have solved a vexing problem by engineering surface coatings that can repel everything, such as bacteria, viruses and living cells, but can be modified to permit beneficial exceptions. The discovery holds significant promise for medical and other applications, making it possible for implants such as vascular grafts, replacement heart valves and artificial joints…
Rutgers University–New Brunswick engineers have created a smart wristband with a wireless connection to smartphones that will enable a new wave of personal health and environmental monitoring devices. Their technology could be added to watches and other wearable devices that monitor heart rates and physical activity.
A team led by the University of California San Diego has developed a chip that can detect a type of genetic mutation known as a single nucleotide polymorphism (SNP) and send the results in real time to a smartphone, computer, or other electronic device. The chip is at least 1,000 times more sensitive at detecting an SNP than current technology. The advance could lead to cheaper, faster and…
For many years, Virtual Reality (VR) has been part of the gaming sector with eye goggles for players to interact with certain scenarios. However, more recently VR has shown it can deliver specific treatments in healthcare. It is already being applied, for example, to treat phobias and as a distraction therapy for pain.
An interdisciplinary team of researchers from Washington University School of Medicine in St. Louis and the School of Engineering & Applied Science is redefining the notion of a wisdom tooth. The team is developing a smart-tooth technology that could someday be used to detect early signs of certain diseases in high-risk patients by analyzing saliva or gingival crevicular fluid.…
In standard settings, the analysis of each DNA modification requires a carefully optimised assay that runs under specific conditions. This increases cost and labour and is a severe limitation to throughput. Now, however, researchers at Stanford University and the Technical University of Denmark have come up with a new method that will enable doctors to make a more precise diagnosis, prognosis and…
Cell-based biosensors can simulate the effect of various substances, such as drugs, on the human body in the laboratory. Depending on the measuring principle, though, producing them can be expensive. As a result, they are often not used. Cost factors for sensors that perform measurements electrically are the expensive electrode material and complex production. Fraunhofer scientists are now…
Just two decades ago, even though promising, point-of-care testing (POCT) was only used in hospitals and surgeries by a small number of specialists. Today POCT is in use throughout healthcare.
Philips and Diagnostics Development, a P&M Venge company, evaluate the novel human neutrophil lipocalin (HNL) biomarker for the rapid detection of bacterial infection. Based on Philips’ Minicare I-20 handheld diagnostics platform, the Minicare HNL assay is recognized for its potential to provide physicians with 10-minute confirmation of bacterial infection, helping to ensure that…
Researchers from the Complutense University of Madrid have developed a biosensor capable of detecting cancer antibodies in patients with colorectal and ovarian cancer.
England’s NHS has received an advanced medical imaging and genomic data integration platform from a global healthcare information systems specialist.
Insulin deficiency and hyperglycemia are two well-known culprits behind diabetes, both of which are reflected in blood glucose concentrations. Now, researchers are working to create ultrasensitive lab-on-a-chip devices to quickly measure glucose concentrations with the goal of developing device for early diagnosis and prevent of diabetes.
Imaging research is one step closer to giving clinicians a way to do high-resolution scans of malignant cells in order to diagnose cancer and help identify useful therapies. If this technology were to prove successful in clinical studies, it might change how anatomic pathologists and radiologists diagnose and treat cancer.
Royal Philips and Banyan Biomarkers, Inc. today announced that they have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care. The new handheld test will be based on Philips’ Minicare I-20 system. The financial details of the…
A new world of flexible, bendable, even stretchable electronics is emerging from research labs to address a wide range of potentially game-changing uses.
The lab of Kai Johnsson at EPFL, led by Alberto Schena and Rudolf Griss, were able to add a small chemical tag on the enzyme luciferase, which produces the light of fireflies. The tag detects a target protein, and the luciferase gives out a light signal that can be seen with a naked eye.
Several EPFL laboratories are working on devices allowing constant analysis over as long a period as possible. The latest development is the biosensor chip, created by researchers in the Integrated Systems Laboratory working together with the Radio Frequency Integrated Circuit Group. Sandro Carrara is unveiling it today at the International Symposium on Circuits and Systems (ISCAS) in Lisbon.
Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen). The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.
Clinical routine would be inconceivable without MR Imaging. Without exposure to radiation, doctors can make a patient’s organs and tissue structures clearly visible. However, pathological changes in the early stages, degenerated cells or small areas of inflammation, have so far remained almost invisible on these images. In 2014, for the first time, a team of cell biologists, chemists and…
New molecular technologies to screen drug-resistant TB are replacing, for example, culture-based tests that are slow, require experienced personnel, and need stringent microbiological safety precautions.
This April, in San Jose, California, the portable lab took central stage at the American Association for Clinical Chemistry’s (AACC) annual forum for emerging clinical diagnostic technologies – a most appropriate topic for the Silicon Valley venue where so many world-changing computer and communications innovations have been born.
The Plaque-CharM project funded by the German Federal Ministry of Education and Research is to develop novel sensor technology that can characterise arterial tissue in the smallest space – the tip of a catheter.
Using electrically conductive, ink-like materials, a Swedish consortium has created a fully functional prototype for a self-monitoring blood glucose (SMBG) test that could be disruptive for in vitro diagnostics.
Frost & Sullivan is carefully tracking the transforming global point-of-care testing (POCT) market, offering latest information on key opportunities and critical unmet needs by region
Scientists in Scotland have developed a new test using a strip with electrical sensors that can show whether wounds or lesions have been infected with bacteria, including MRSA, Mark Nicholls reports. The hand-held test provides rapid results and allows almost immediate detection of bacteria, which means patients can be given more effective drugs much quicker and speed up their recovery.
According to estimates up to 450 million patients will suffer from diabetes in the year 2025 (currently 250 million). In view of this, glucose monitoring is of utmost importance. Scientific studies and practical experiences with glucose monitoring at the point of care (POC) were evaluated recently during a meeting of experts in Vienna.
Clinical laboratory scientists, the medical technologists of the 21st century, are not only enjoying a rapidly expanding role in clinical work but are also increasingly undertaking non-clinical duties such as consultation, quality assurance, laboratory management, professional advocacy and education.
This year's AACC, held in conjunction with the Canadian Society for Clinical Chemists, and the Annual Meeting of the American Society for Clinical Laboratory Science, featured around 200 educational sessions and drew in over 18,000 delegates and exhibitors from almost 100 countries.
Marcel van Kasteel MBA, is VP of Philips and CEO of Handheld Immunoassays, a Philips Incubator venture in Eindhoven, the Netherlands, which recently announced that, by the end of this year, the first device to test for drug abuse will be marketed that will make on the spot testing simple and quick for use by the police.
Bio-medical technology firm Itamar Medical Ltd develops and markets diagnostic medical equipment based on its proprietary Peripheral Arterial Tone (PAT) Technology.
Scientists in Singapore are reporting their development of a complete, palm-sized sensor that can detect disease-causing microbes, toxins, and other biological threats instantly without the need for an external power source or a computer.
Urinary tract infections caused by catheterisation are a common and nasty affliction for the disabled, elderly and hospital patients.
By Paolo Montuschi MD, of the Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy.
The MPOWER project aims to help older people to live independently and well, in their own homes, for as long as possible.